BGB-A317-310
Active, not recruiting
Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma
Study Overview
Sex: All
Age: 18 Years / 75 Years
Accepts Healthy Volunteers? No
No Study Documents
Study Overview
Sex: All
Age: 18 Years / 75 Years
Accepts Healthy Volunteers? No
No Study Documents